alpha-aminopyridine has been researched along with Dyspnea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Keechilat, P; Kunoor, A; Pushpa Ragahavan, R; Rajendran, A | 1 |
| Braun, A; Dezube, R; Grant, J; Hong, G; Jennings, MT; Lechtzin, N; Merlo, CA; Paranjape, S; West, NE | 1 |
| Catherinot, E; Chabrol, A; Chaumais, MC; Couderc, LJ; Doubre, H; Fraboulet, S; Friard, S; Hamid, AM; Mayenga, M; Metivier, AC; Montani, D; Rivaud, E; Salvator, H; Tcherakian, C | 1 |
| Bredenbröker, D; Calverley, PM; Goehring, UM; Rennard, SI; Rowe, P; Sun, SX; Tourkodimitris, S | 1 |
| Bateman, ED; Bredenbröker, D; Brose, M; Calverley, PM; Fabbri, LM; Goehring, UM; Rabe, KF | 1 |
| Bredenbröker, D; Brose, M; O'Donnell, DE; Webb, KA | 1 |
1 review(s) available for alpha-aminopyridine and Dyspnea
| Article | Year |
|---|---|
Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials.
Topics: Aged; Aminopyridines; Benzamides; Cyclopropanes; Dyspnea; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Recovery of Function; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
2 trial(s) available for alpha-aminopyridine and Dyspnea
| Article | Year |
|---|---|
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history.
Topics: Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Aminopyridines; Benzamides; Bronchodilator Agents; Cyclopropanes; Dyspnea; Female; Humans; Lung; Male; Middle Aged; Placebos; Pulmonary Disease, Chronic Obstructive; Regression Analysis | 2011 |
Physiological effects of roflumilast at rest and during exercise in COPD.
Topics: Aged; Airway Resistance; Aminopyridines; Benzamides; Bronchodilator Agents; Cyclopropanes; Drug Administration Schedule; Dyspnea; Exercise; Female; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Physical Endurance; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Rest; Severity of Illness Index | 2012 |
3 other study(ies) available for alpha-aminopyridine and Dyspnea
| Article | Year |
|---|---|
Ribociclib-associated organising pneumonia.
Topics: Aminopyridines; Cough; Dyspnea; Humans; Middle Aged; Pneumonia; Purines | 2021 |
An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Dyspnea; Female; Forced Expiratory Volume; Humans; Logistic Models; Lung; Male; Middle Aged; Mutation; Quinolones; Retrospective Studies; Young Adult | 2017 |
Lorlatinib - Induced pulmonary arterial hypertension.
Topics: Aminopyridines; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Humans; Hypertension, Pulmonary; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Vascular Resistance; Walk Test; Withholding Treatment | 2018 |